FDA Approves OXYCODONE AND ACETAMINOPHEN — SpecGx LLC
SpecGx LLC received FDA approval for a generic version of the combination pain reliever oxycodone hydrochloride and acetaminophen, offering the agency an additional ANDA product to counteract shortages in the opioids market. (Original source)
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day